全文获取类型
收费全文 | 25825篇 |
免费 | 1878篇 |
国内免费 | 71篇 |
专业分类
耳鼻咽喉 | 233篇 |
儿科学 | 878篇 |
妇产科学 | 711篇 |
基础医学 | 3118篇 |
口腔科学 | 272篇 |
临床医学 | 4016篇 |
内科学 | 4756篇 |
皮肤病学 | 322篇 |
神经病学 | 2556篇 |
特种医学 | 558篇 |
外科学 | 2259篇 |
综合类 | 276篇 |
现状与发展 | 1篇 |
一般理论 | 64篇 |
预防医学 | 3795篇 |
眼科学 | 349篇 |
药学 | 1449篇 |
1篇 | |
中国医学 | 26篇 |
肿瘤学 | 2134篇 |
出版年
2023年 | 105篇 |
2022年 | 145篇 |
2021年 | 443篇 |
2020年 | 321篇 |
2019年 | 488篇 |
2018年 | 591篇 |
2017年 | 470篇 |
2016年 | 490篇 |
2015年 | 543篇 |
2014年 | 850篇 |
2013年 | 1348篇 |
2012年 | 1827篇 |
2011年 | 1896篇 |
2010年 | 1060篇 |
2009年 | 965篇 |
2008年 | 1736篇 |
2007年 | 1833篇 |
2006年 | 1822篇 |
2005年 | 1854篇 |
2004年 | 1769篇 |
2003年 | 1683篇 |
2002年 | 1549篇 |
2001年 | 198篇 |
2000年 | 131篇 |
1999年 | 255篇 |
1998年 | 354篇 |
1997年 | 252篇 |
1996年 | 254篇 |
1995年 | 245篇 |
1994年 | 203篇 |
1993年 | 187篇 |
1992年 | 124篇 |
1991年 | 108篇 |
1990年 | 88篇 |
1989年 | 103篇 |
1988年 | 85篇 |
1987年 | 78篇 |
1986年 | 81篇 |
1985年 | 99篇 |
1984年 | 119篇 |
1983年 | 117篇 |
1982年 | 138篇 |
1981年 | 123篇 |
1980年 | 115篇 |
1979年 | 59篇 |
1978年 | 70篇 |
1977年 | 74篇 |
1976年 | 52篇 |
1975年 | 50篇 |
1974年 | 49篇 |
排序方式: 共有10000条查询结果,搜索用时 250 毫秒
21.
22.
23.
24.
Potential aripiprazole-mediated extrapyramidal symptoms in an adult with developmental disabilities.
Nancy C Brahm David L McElwain Robert C Brown 《American journal of health-system pharmacy》2007,64(8):827-829
PURPOSE: A case of extrapyramidal symptoms (EPS) following administration of aripiprazole to a man with developmental disabilities who had never received antipsychotic medications and had no history of movement disorders is presented. SUMMARY: The patient was a 40-year-old male with developmental disabilities. He was nonverbal, profoundly mentally retarded, and diagnosed with obsessive compulsive disorder (OCD) and orthopedic problems. He developed episodic movements possibly consistent with EPS secondary to aripiprazole usage. The patient was antipsychotic naive before initiation of aripiprazole 5 mg daily. Concurrent medications at the time of EPS onset included oxazepam, baclofen, and citalopram. Baclofen and oxazepam were prescribed secondary to right-sided hemiparesis contractures. Aripiprazole, 5 mg daily, was initiated in November 2004 as an augmentation strategy for the diagnosis of OCD. Facial, tongue, and arm movements were first reported approximately five weeks after the initiation of aripiprazole. Initial symptoms resolved after approximately 24 hours. The dosage was increased to 10 mg daily two weeks later. Dystonic episodes continued on an intermittent basis, and the patient presented with lower-lip thrusting and upper-limb athetosis. These movements interfered with the patient's eating, chewing, and holding of utensils. Several of the standard treatment strategies for EPS were used. Initially, diphenhydramine hydrochloride 25 mg was administered orally every six hours. The patient's movements resolved following diphenhydramine administration. Aripiprazole was subsequently discontinued secondary to its lack of efficacy for OCD and the development of a movement disorder. CONCLUSION: A patient with developmental disabilities who had no history of movement disorders developed EPS following initiation of aripiprazole. 相似文献
25.
26.
Mary Locniskar PhD Kathleen M. Nauss PhD Paul M. Newberne DVM PhD 《Digestive diseases and sciences》1987,32(7):747-752
Twoin vitro models of immune surveillance were used to examine the immune status of the gut-associated lymphoid tissue, mesenteric lymph nodes, and spleen during the early stages of 1,2-dimethylhydrazine (DMN)-induced colon tumorigenesis. DMH-and vehicletreated Fischer rats were sacrificed at one of three time points; one week, two months, or five months after cessation of treatment. Colonic, lymph node, and splenic natural killer cell cytolytic activity toward YAC-1 tumor targets and T-cell response to autologous la-induced balstogenesis were measured at each time point. We found little change in natural killer cell activity or T-cell proliferation induced by autologous Ia gene products at these time periods.This investigation was supported in part by grant CA26917 from the National Cancer Institute, Department of Health and Human Services. 相似文献
27.
28.
Background
The mitogen-activated protein kinases, MAPKs for short, constitute cascades of signalling pathways involved in the regulation of several cellular processes that include cell proliferation, differentiation and motility. They also intervene in neurological processes like fear conditioning and memory. Since little remains known about the MAPK-Activated Protein Kinase, MAPKAPK5, we constructed the first MAPKAPK knockin mouse model, using a constitutive active variant of MAPKAPK5 and analyzed the resulting mice for changes in anxiety-related behaviour. 相似文献29.
Adam J. Singer MD Steve A. McClain MD Alexander Romanov DVM Jean Rooney BS Tom Zimmerman DVM 《Academic emergency medicine》2007,14(12):1125-1129
Objectives Cutaneous burns are dynamic injuries with a central zone of necrosis surrounded by a zone of ischemia. Conversion of this ischemic zone to full necrosis over the days following injury is due in part to highly reactive oxygen radicals. Curcumin is a component of the Oriental spice turmeric that has been shown to have antioxidant and antiapoptotic properties. The authors hypothesized that treatment of burns with curcumin would reduce the conversion of the ischemic zone to full necrosis. Methods This was a randomized controlled experiment. Twenty Sprague‐Dawley rats were used. Two burns were created on each animal's dorsum using a brass comb with four rectangular prongs preheated in boiling water and applied for 30 seconds, resulting in four rectangular 10 × 20–mm full‐thickness burns separated by three 5 × 20–mm unburned interspaces (zone of ischemia). Animals were randomized to curcumin or vehicle by oral gavage 30 minutes before injury and at 24, 48, and 72 hours after injury. Wounds were observed at one, two, and three days after injury for visual evidence of necrosis in the unburned interspaces. Full‐thickness biopsy specimens from the interspaces were evaluated with hematoxylin and eosin staining seven days after injury for evidence of necrosis. The percentage of interspaces that progressed to necrosis was compared with chi‐square tests. Results Forty comb burns with 120 unburned interspaces were created, evenly distributed between curcumin and vehicle alone. The percentage of interspaces that progressed to full‐thickness necrosis at one, two, three, and seven days after injury in the curcumin and vehicle groups were 30% versus 63% (p = 0.003), 30% versus 70% (p < 0.001), 63% versus 95% (p = 0.02), and 63% versus 95% (p = 0.02), respectively. Conclusions Pretreatment of rats with oral curcumin followed by once‐daily oral treatment for three days reduced the percentage of unburned skin interspaces that progressed to full necrosis. 相似文献
30.